Evaluation a novel vitronectin:growth factor complex for treatment of chronic venous leg ulcers

新型玻连蛋白：生长因子复合物治疗慢性下肢静脉溃疡的评价

• 批准号: nhmrc : 513877
• 负责人: A/Pr Hilary Wallace
• 金额: $ 57.01万
• 依托单位: The University of Western Australia
• 依托单位国家: 澳大利亚
• 项目类别: NHMRC Project Grants
• 财政年份: 2008
• 资助国家: 澳大利亚
• 起止时间: 2008-01-01 至 2015-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/evaluation-novel-vitronectingrowth-leg-ulcers/99448
• 关键词: Evaluation; novel; vitronectin; growth; factor

Chronic leg ulcers in the elderly are an important problem, diminshing quality of life and costing at least A$1 billion per year. New treatments are urgently required. This study will test a new topical growth factor therapy designed to have greatly improved activity in wounds.The project is a collaboration between scientists and doctors at the Queensland Univeristy of Technology and the University of Western Australia. Many wound types may ultimately benefit from this treatment.

老年人的慢性腿部溃疡是一个重要问题，降低了生活质量，每年至少花费10亿澳元。迫切需要新的治疗方法。这项研究将测试一种新的局部生长因子疗法，旨在大大提高伤口的活性。该项目是昆士兰州科技大学和西澳大利亚大学的科学家和医生之间的合作。许多类型的伤口可能最终受益于这种治疗。